Royalty Report: Drugs, Drug Discovery, cell therapy – Collection: 362515

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Drugs
  • Drug Discovery
  • cell therapy

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 362515

License Grant
The University grants an exclusive, worldwide right and license with rights to sublicense the Licensed Subject Matter with rights to use, develop, make, have made, market, sell, offer to sell and otherwise commercially exploit Licensed Products.
License Property
The patents include Super-Active Porcine Growth Hormone Releasing Hormone Analog, and,
Increasing Growth in Offspring through Administration of Growth Hormone releasing Hormone to Pregnant Mothers.

'Jointly Owned Patent Rights' shall mean the United States Patent Application entitled 'Growth Hormone Releasing Hormone Expression System and Methods of Use, Including Use in Animals' US Patent Application Serial No. 09/122, 171.

IPSCIO Record ID: 362514

License Grant
For the License to Jointly Owned Patent Rights and Joint Technology Rights, the University and Co-Licensor each grant Licensee a worldwide, exclusive license in the Field of Interest to the Jointly Owned Patent Rights and the Joint Technology Rights with rights to develop, make and have made, use, sell, market, import, distribute and otherwise commercially exploit Licensed Products.

For the License to Sublicensed Patent Rights and Sublicensed Technology Rights, the Co-Licensor grants Licensee a worldwide, exclusive sublicense in the Field of Interest to the Sublicensed Patent Rights, and the Sublicensed Technology Rights, with rights to develop, make and have made, use, sell, market, import, distribute and otherwise commercially exploit Licensed Products.

For the License to the Co-Licensor Patents, Co-Licensor Technology and Improvements, the Co-Licensor grants to Licensee a worldwide, nonexclusive license in the Field of Interest to the Co-Licensors Patent Rights, Technology Rights and Improvements with rights to develop, make and have made, use, sell, market, import, distribute and otherwise commercially exploit Co-Licensor Licensed Products; provided that Co-Licensor does not need to notify Licensee of any Co-Licensor Improvements.

For the License to University Improvements, the University grants to Licensee a worldwide, exclusive license in the Field of Interest to the University Improvements with rights to develop,
make and have made, use, sell, market, import, distribute and otherwise commercially exploit Licensed Products.

License Property
The technology and patents relate to
Method for the Identification of Synthetic Cell or Tissue Specific Transcriptional Regulatory Regions;
Myogenic Vector Systems;
Formulated Nucleic Acid Composition and the Method of Administering the Same, and,
the Jointly Owned Patent Rights entitled Growth Hormone Releasing Hormone Expression System and Methods of Use, Including Use in Animals.
Field of Use
The Field of Interest shall mean the use of genes within the Growth Hormone Axis for therapeutic and growth applications in livestock and companion animals.

Licensees New Technology shall mean any technology reduced to practice by Licensee that involves the delivery of genes or gene products into a cell.

IPSCIO Record ID: 289234

License Grant
The Licensors grant the exclusive right and license to utilize the Applications and the Technologies in the rendering of services, the manufacture and sale of products and the further licensing of the Applications and Technologies to others.
License Property
Licensors have patents and invented methods for amidating peptides using transpeptidation techniques and a photo-nucleophile and other nucleophiles, referred to herein as the Technologies.
Field of Use
Licensee in to develop and commercialize the certain technologies and know-how which are to be applied relative to the recombinant expression and production of peptides, including amidated peptides.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.